CD 27 + B cells from a subgroup of common variable immunodeficiency patients are less sensitive to apoptosis rescue regardless of interleukin‐21 signalling
Author(s) -
Clemente A.,
Pons J.,
Lanio N.,
Matamoros N.,
Ferrer J. M.
Publication year - 2013
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.12150
Subject(s) - common variable immunodeficiency , apoptosis , immunology , biology , antibody , cd40 , interleukin 10 , immunodeficiency , immune system , b cell , in vitro , cytotoxic t cell , biochemistry
Summary Common variable immunodeficiency ( CVID ) is a primary immunodeficiency characterized by hypogammaglobulinaemia and recurrent infections. Although the underlying cause is unknown, B cells from most CVID patients fail to differentiate to memory or plasma cells. We investigated if increased apoptosis could influence the fate of B cells. For this purpose we activated purified B lymphocytes of CVID patients with a surrogate T ‐dependent (anti‐ CD 40) or T ‐independent [cytosine–phosphate–guanosine oligodeoxynucleotides ( CpG‐ODN ) or anti‐immunoglobulin ( Ig)M )] stimulus with or without interleukin ( IL )‐21. We found that CD 27 + B cells were more sensitive than CD 27 – B cells to spontaneous apoptosis and less sensitive to rescue from apoptosis. The addition of IL ‐21 down‐modulated the protective effect of all the stimuli on CD 27 – B cells and the protective effect of CpG ‐ ODN and anti‐ IgM on CD 27 + B cells. In contrast, IL ‐21 rescued unstimulated CD 27 – B cells and improved the rescue of anti‐ CD 40‐stimulated CD 27 + B cells. When we compared patients and controls, mainly CD 27 + B cells from MB0 patients were less sensitive to rescue from apoptosis than those from MB 1 patients and controls after activation, irrespective of the IL ‐21 effect. Increased apoptosis during an immune response could result in lower levels of immunoglobulin production in these patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom